Interplay between the EU Clinical Trials Regulation and the GDPR
Clinical trial sponsors should take into account data protection compliance in the early development of the trial to enable its authorization in the EU. By Laura Brodahl and Jan Dhont of Wilson Sonsini Goodrich & Rosati.
With the entry into application of the European Union’s (EU) Clinical Trials Regulation (CTR)(1), an additional emphasis is put on data protection compliance during clinical trials. This article explains the interplay between the CTR and the existing EU data protection rules, followed by a high-level overview of key privacy compliance items that are impacted by the CTR. This article does not address any specific obligations that may be imposed by national laws.
The CTR entered into application on 31 January 2022. It applies to all clinical trials conducted in the EU.(2) In layman terms, a clinical trial is a study performed to investigate the safety or efficacy of a medicine. For human medicines, these studies are carried out on human volunteers.(3)
UK Report subscribers, to access the full article, please
If you wish to subscribe please see our subscription information.